Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults. [electronic resource]
Producer: 20170522Description: 1717-1727 p. digitalISSN:- 1537-6613
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Antibodies, Viral -- blood
- Drug Combinations
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Healthy Volunteers
- Humans
- Immunization Schedule
- Influenza A Virus, H7N9 Subtype -- immunology
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- prevention & control
- Male
- Middle Aged
- Placebos -- administration & dosage
- Polysorbates -- administration & dosage
- Single-Blind Method
- Squalene -- administration & dosage
- Vaccines, Inactivated -- administration & dosage
- Young Adult
- alpha-Tocopherol -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.